The Board of Directors at Mironid provides strategic guidance, ensures corporate governance, and oversees the company's management to drive growth and success in developing therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer. The board members collectively bring diverse expertise and experience to make informed decisions that align with the company's mission and goals.
View all